TotalMarketCap

Camp4 Therapeutics

CAMPNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$233.442 M

$3.72 -0.54%

Close of 6 Nov 2026

As of 6 Nov 2026, Camp4 Therapeutics (CAMP) has a market capitalization of $233.4M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$3.50M

#3318 by revenue

Earnings

-$80.4M

Loss-making

Shares outstanding

62,754,200

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #234Lifecore Biomedical, Inc. DeLFCR$242.4M
  2. #235Amarin Corp PlcukAMRN$238.3M
  3. #236Camp4 TherapeuticsCAMP$233.4M
  4. #237Abeona TherapeuticsABEO$224.4M
  5. #238Korro BioKRRO$219.3M

What if Camp4 Therapeutics were worth as much as…

Open the what-if tool →

Gold $28.2T

$449,967.07

Per share 120,959× higher

Bitcoin $1.53T

$24,346.93

Per share 6,545× higher

Apple $5.02T

$79,928.71

Per share 21,486× higher

Or at a round number

$500.0M$1.00B$2.00B$5.00B

Where these numbers come from

Share counts and financials for Camp4 Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.